Fingerprick Lab Test Startup Theranos Strikes Insurance Deal
This article is for subscribers only.
Theranos Inc., the health startup that performs many routine tests with only a fingerprick’s worth of blood, plans to announce for the first time that it will become the preferred lab-work provider for a health insurer.
Capital BlueCross, a Pennsylvania insurer that covers 725,000 consumers, will promote the California company’s tests. Theranos also will open new blood-work locations, called “wellness centers,” on the East Coast for the first time, Chief Executive Officer Elizabeth Holmes said.